Medartis Holding AG (MDRSF)
USD 66.68
(0.0%)
USD 66.68
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 20.15 Million CHF | -40.72% |
| 2022 | 33.99 Million USD | 152.95% |
| 2021 | -64.19 Million USD | -2.14% |
| 2020 | -62.85 Million USD | 16.79% |
| 2019 | -75.53 Million USD | 33.09% |
| 2018 | -112.88 Million CHF | -255.49% |
| 2017 | 72.6 Million CHF | 15.37% |
| 2016 | 62.92 Million CHF | -19.72% |
| 2015 | 78.38 Million CHF | 6.59% |
| 2014 | 73.53 Million CHF | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -119.88 Million CHF | -694.91% |
| 2024 Q2 | -119.88 Million CHF | 0.0% |
| 2023 Q3 | -4.11 Million CHF | -113.3% |
| 2023 Q1 | 12.42 Million CHF | -63.46% |
| 2023 FY | 20.15 Million CHF | -40.72% |
| 2023 Q4 | 20.15 Million CHF | 590.06% |
| 2023 Q2 | 30.91 Million USD | 148.84% |
| 2022 Q1 | 11.74 Million CHF | 120.05% |
| 2022 Q3 | 2.19 Million CHF | -86.07% |
| 2022 Q4 | 33.99 Million USD | 1450.72% |
| 2022 FY | 33.99 Million USD | 152.95% |
| 2022 Q2 | 15.73 Million CHF | 34.02% |
| 2021 Q1 | -66.9 Million CHF | -20.42% |
| 2021 FY | -64.19 Million USD | -2.14% |
| 2021 Q4 | -58.56 Million CHF | 13.59% |
| 2021 Q3 | -67.77 Million CHF | -15.33% |
| 2021 Q2 | -58.76 Million CHF | 12.17% |
| 2020 FY | -62.85 Million USD | 16.79% |
| 2020 Q4 | -55.55 Million CHF | 14.81% |
| 2020 Q3 | -65.21 Million CHF | -3.55% |
| 2020 Q2 | -62.97 Million CHF | 9.15% |
| 2020 Q1 | -69.32 Million CHF | 5.22% |
| 2019 Q4 | -73.14 Million CHF | 5.28% |
| 2019 Q2 | -79.08 Million CHF | -2.12% |
| 2019 Q1 | -77.44 Million CHF | 31.4% |
| 2019 FY | -75.53 Million USD | 33.09% |
| 2019 Q3 | -77.22 Million CHF | 2.36% |
| 2018 Q1 | -124.04 Million CHF | -270.86% |
| 2018 FY | -112.88 Million CHF | -255.49% |
| 2018 Q3 | -116.77 Million CHF | 1.35% |
| 2018 Q2 | -118.36 Million CHF | 4.58% |
| 2018 Q4 | -112.88 Million CHF | 3.33% |
| 2017 Q3 | 72.54 Million CHF | 0.0% |
| 2017 FY | 72.6 Million CHF | 15.37% |
| 2017 Q4 | 72.6 Million CHF | 0.08% |
| 2017 Q1 | 1.75 Million CHF | 0.0% |
| 2016 FY | 62.92 Million CHF | -19.72% |
| 2015 FY | 78.38 Million CHF | 6.59% |
| 2014 FY | 73.53 Million CHF | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | 176.82% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 287974.243% |
| Össur hf. | 395.08 Million USD | 94.899% |
| QHSLab, Inc. | 1.72 Million USD | -1064.829% |
| Wellstar International, Inc. | 51.36 Million USD | 60.77% |
| Össur hf. | 395.08 Million USD | 94.899% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | -6283.304% |
| Aurora Spine Corporation | 1.9 Million USD | -956.333% |
| BrainsWay Ltd. | -10.32 Million USD | 295.264% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.82 Million USD | -35.913% |
| Hamilton Thorne Ltd. | 18.12 Million USD | -11.173% |
| Vivos Inc. | -1.59 Million USD | 1365.551% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -4034.995% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 3824.902% |
| Zecotek Photonics Inc. | 2.76 Million USD | -629.468% |
| Avitar, Inc. | 5.17 Million USD | -289.684% |
| Nanomix Corporation | 11.38 Million USD | -76.933% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 536.44% |
| Theraclion SA | -5.86 Million EUR | 443.611% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.68 Million USD | -1094.584% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -1150.973% |
| Lombard Medical, Inc. | 11.49 Million USD | -75.304% |
| ALR Technologies Inc. | 19.14 Million USD | -5.238% |
| Stratec SE | 119.12 Million USD | 83.084% |
| Vycor Medical, Inc. | 1.05 Million USD | -1813.772% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -36541.871% |
| MicroPort Scientific Corporation | 673.58 Million USD | 97.008% |
| VMS Rehab Systems, Inc. | 133.52 USD | -15092168.574% |
| NewCardio, Inc. | 2.41 Million USD | -734.409% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -1273.634% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -3093.944% |
| Odyssey Group International, Inc. | 2.1 Million USD | -856.032% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -3047.656% |
| Wellness Center USA, Inc. | 3.98 Million USD | -405.615% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 33.157% |
| IR-Med Inc. | -606 Thousand USD | 3425.28% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 246.158% |
| Polarean Imaging plc | -5.94 Million USD | 438.873% |
| United American Healthcare Corporation | -9.32 Million USD | 316.052% |
| ECGI Holdings, Inc. | 3.17 Million USD | -535.435% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -21522.848% |
| Capital Group Holdings, Inc. | -3508.00 USD | 574535.49% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -7573.197% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -9203.071% |
| Urologix, Inc. | 4.61 Million USD | -336.646% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -378.716% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -504.915% |
| SS Innovations International, Inc. | 1.18 Million USD | -1600.028% |
| Qualis Innovations, Inc. | 6671.00 USD | -301971.608% |
| Smith & Nephew plc | 2.77 Billion USD | 99.275% |
| NIOX Group Plc | -23.93 Million USD | 184.2% |
| Fuse Medical, Inc. | 1.75 Million USD | -1047.893% |
| Broncus Holding Corporation | -81.42 Million USD | 124.748% |
| Brain Scientific Inc. | 2.11 Million USD | -852.428% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 11.139% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -50842.177% |